Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DB26FD4RD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,524
Award facts
- Contract value 100% obligated
- $15,524.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $15,524.40 to DMS Pharmaceutical Group Inc. for 200-unit vials of BOTOX on October 30, 2025, with an ultimate completion date of November 21, 2025. This firm fixed-price delivery order was issued without a set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, serves as a critical supplier within the federal pharmaceutical supply chain, particularly for the Department of Defense.
This delivery order was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that establishes multiple regional prime vendor contractors. The underlying IDC, designated contract SPE2DR, has a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period followed by three 30-month option periods. DMS Pharmaceutical Group's established performance on numerous delivery orders across diverse therapeutic categories, including specialty pharmaceuticals and biologics, demonstrates its capability to fulfill the specialized pharmaceutical requirements of military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DB26FD4RD?
SPE2DB26FD4RD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FD4RD worth?
The government has obligated $15,524 on SPE2DB26FD4RD.
Is contract SPE2DB26FD4RD an order under another contract?
Yes. SPE2DB26FD4RD is a delivery order under SPE2DB20D9214, an indefinite delivery contract.
Was contract SPE2DB26FD4RD competed?
The extent of competition for SPE2DB26FD4RD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award